1. Inhibitory Effects of Anti-VEGF Antibody on the Growth and Angiogenesis of Estrogen-induced Pituitary Prolactinoma in Fischer 344 Rats: Animal Model of VEGF-targeted Therapy for Human Endocrine Tumors
   Katsuhiro Miyajima et al, 2010, ACTA HISTOCHEMICA ET CYTOCHEMICA CrossRef
2. Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells
   Kimi Fukahi et al, 2004, Clinical Cancer Research CrossRef
3. PTTG has a Dual Role of Promotion-Inhibition in the Development of Pituitary Adenomas
   Zujian Xiong et al, 2019, Protein & Peptide Letters CrossRef
4. Immunotherapy and potential molecular targets for the treatment of pituitary adenomas resistant to standard therapy: a critical review of potential therapeutic targets and current developments
   Tamara Maghathe et al, 2020, Journal of Neurosurgical Sciences CrossRef
5. Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol
   Krishanu Sengupta et al, 2004, Molecular Cancer Research CrossRef
6. Therapeutic targeting of the pituitary tumor microenvironment
   Mirela-Diana Ilie et al, 2023, Pharmacology & Therapeutics CrossRef
7. Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
   Congxin Dai et al, 2021, Frontiers in Oncology CrossRef